Results 211 to 220 of about 27,184 (256)
Some of the next articles are maybe not open access.
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.
The Lancet Gastroenterology and HepatologyY. Lim, Ming-Lung Yu, Jonggi Choi, Chi-Yi Chen, Won Choi, Wonseok Kang, Gi-Ae Kim, Hyung Joon Kim, Y. Lee, Jeong-Hoon Lee, N. Park, So Young Kwon, Soo Young Park, Ji Hoon Kim, G. Choi, Eun Sun Jang, Chien-Hung Chen, Yao-Chun Hsu, M.-J. Bair, Pin-Nan Cheng, H. Tung, T. Chang, Ching-Chu Lo, K. Tseng, Sheng-Shun Yang, Cheng-Yuan Peng, Seungbong Han +26 moresemanticscholar +1 more sourceEfficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet, The, 2021 Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie +2 moreexaly
